Alex Bangs

Alex is Founder & Principal of Allevo Advisors, providing technology, product, commercial, and organizational strategy consulting services to organizations focused on digital health, diagnostics, devices, and life science analytics.

Alex most recently served as Chief Information Officer at Vir Biotechnology, Inc, a San Francisco-based infectious disease therapeutics company. Alex joined in 2018 to set up Data Science and IT organizations for this fast-growing startup, building out a cloud-first data and IT infrastructure and multidisciplinary team to support lab research, clinical trials, contract manufacturing, quality, and administrative operations. Vir became a public company in 2019, and in 2020 discovered and co-developed the sorovimab antibody that was used globally in the fight against COVID-19.

Previously, Alex served as Chief Information Officer of Crescendo Bioscience, a startup focused on molecular diagnostics for autoimmune rheumatic diseases. At Crescendo, Alex led Informatics, IT, and Information Security, developing external web and mobile solutions for patients and physicians, and internal data and analytics solutions for scientific and commercial staff. He also provided leadership to other functions across the company including laboratory operations, customer service, and clinical trial design. Crescendo was acquired by Myriad Genetics in 2014.

Prior to Crescendo, Alex was Co-Founder and Chief Technology Officer at Entelos where he led the development of technology for virtual patient simulations and is an inventor on several related patents. He has held technical and management positions at Strategic Decisions Group, Oak Ridge National Laboratory, Honeybee Robotics, and the Institute for Defense Analyses. He received an AB in computer science and engineering sciences from Harvard College and an MS in computer science from the University of Tennessee.